Mostafi M, Jabin M, Chowdhury Z, Khondoker M, Ali S, Tamanna R, Rezwan R, Alomgir S. The outcome of Daclatasvir and low dose Sofosbuvir therapy in end-stage renal disease patients with hepatitis C virus infection. Ukr. J. Nephrol. Dial. [Internet]. 2020Apr.16 [cited 2026Jun.26];0(2(66):3-. Available from: https://ukrjnd.com.ua/index.php/journal/article/view/404